ResMed to Announce First Quarter Fiscal Year 2016 Results

SAN DIEGO, Sept. 24, 2015 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced it will report its first quarter of fiscal year 2016 results on Thursday, October 22, 2015, after the New York Stock Exchange market close. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a webcast to discuss operating results and future outlook.

The earnings call is scheduled to begin at 1:30 p.m. US Pacific Time and the live webcast of the call can be accessed on ResMed's Investor Relations website at Please go to this section of the website and click on the icon for the "Q1 2016 earnings webcast."

Please note that we do not use outside conference lines to access the earnings call.

International earnings webcast times will be:

                        9:30 p.m.         London
                        7:30 a.m.         Sydney, Australia (October 23, 2015)

A replay of the earnings webcast will be accessible on our website and available approximately two hours after the webcast.  In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from October 22, 2015 until November 5, 2015 at:

US:   855-859-2056      Outside US:   +1 404-537-3406   Passcode:    43449699

About ResMed
The global team at ResMed (NYSE:RMD) is united in the commitment to change millions of  lives with every breath.  With more than 4,000 employees and a presence in over 100 countries, the company has been pioneering new and innovative devices and treatments for sleep-disordered breathing, chronic obstructive pulmonary disease, and other key chronic diseases for more than 25 years. ResMed's world-leading products and innovative solutions improve the quality of life for millions of patients worldwide, reduce the impact of chronic disease, and save healthcare costs. For more information about ResMed and its businesses, visit or follow @resmed on Twitter.

ResMed Contacts:

For News Media     

For Investors

Alison Graves            

Agnes Lee

Global Corporate Communications                           

Senior Director, Investor Relations

O: 858-836-6789                                                        

O: 858-836-5971                                          


ResMed Inc. logo.

Logo -


To view the original version on PR Newswire, visit:

SOURCE ResMed Inc.